Turkaydin B, Schewe M, Riel E, Schulz F, Biedermann J, Baukrowitz T
Nat Commun. 2024; 15(1):4628.
PMID: 38821927
PMC: 11143257.
DOI: 10.1038/s41467-024-48823-y.
Immanuel C, Teng B, Dong B, Gordon E, Luellen C, Lopez B
Am J Physiol Lung Cell Mol Physiol. 2024; 326(3):L367-L376.
PMID: 38252657
PMC: 11281793.
DOI: 10.1152/ajplung.00313.2023.
Hatakama H, Asaoka N, Nagayasu K, Shirakawa H, Kaneko S
Transl Psychiatry. 2024; 14(1):27.
PMID: 38228604
PMC: 10791614.
DOI: 10.1038/s41398-024-02731-3.
Schmidpeter P, Petroff 2nd J, Khajoueinejad L, Wague A, Frankfater C, Cheng W
Nat Commun. 2023; 14(1):1077.
PMID: 36841877
PMC: 9968290.
DOI: 10.1038/s41467-023-36765-w.
Bavi O, Zhou Z, Bavi N, Allaei S, Cox C, Martinac B
Sci Rep. 2022; 12(1):9976.
PMID: 35705645
PMC: 9200802.
DOI: 10.1038/s41598-022-14446-w.
The Polysite Pharmacology of TREK K Channels.
Pope L, Minor Jr D
Adv Exp Med Biol. 2022; 1349:51-65.
PMID: 35138610
PMC: 8887811.
DOI: 10.1007/978-981-16-4254-8_4.
The versatile regulation of K2P channels by polyanionic lipids of the phosphoinositide and fatty acid metabolism.
Riel E, Jurs B, Cordeiro S, Musinszki M, Schewe M, Baukrowitz T
J Gen Physiol. 2021; 154(2).
PMID: 34928298
PMC: 8693234.
DOI: 10.1085/jgp.202112989.
Convergence of Multiple Stimuli to a Single Gate in TREK1 and TRAAK Potassium Channels.
Choveau F, Ben Soussia I, Bichet D, Franck C, Feliciangeli S, Lesage F
Front Pharmacol. 2021; 12:755826.
PMID: 34658895
PMC: 8514629.
DOI: 10.3389/fphar.2021.755826.
Negative Influence by the Force: Mechanically Induced Hyperpolarization via K Background Potassium Channels.
Lengyel M, Enyedi P, Czirjak G
Int J Mol Sci. 2021; 22(16).
PMID: 34445768
PMC: 8396510.
DOI: 10.3390/ijms22169062.
Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092.
Walsh Y, Leach M, Veale E, Mathie A
Biochem Biophys Rep. 2021; 26:101021.
PMID: 34041373
PMC: 8144350.
DOI: 10.1016/j.bbrep.2021.101021.
The anchor domain is critical for Piezo1 channel mechanosensitivity.
Li J, Cox C, Martinac B
Channels (Austin). 2021; 15(1):438-446.
PMID: 33975519
PMC: 8118467.
DOI: 10.1080/19336950.2021.1923199.
Channelling the Force to Reprogram the Matrix: Mechanosensitive Ion Channels in Cardiac Fibroblasts.
Stewart L, Turner N
Cells. 2021; 10(5).
PMID: 33922466
PMC: 8145896.
DOI: 10.3390/cells10050990.
Structural Insights into the Mechanisms and Pharmacology of K Potassium Channels.
Natale A, Deal P, Minor Jr D
J Mol Biol. 2021; 433(17):166995.
PMID: 33887333
PMC: 8436263.
DOI: 10.1016/j.jmb.2021.166995.
The Pharmacology of Two-Pore Domain Potassium Channels.
Kamuene J, Xu Y, Plant L
Handb Exp Pharmacol. 2021; 267:417-443.
PMID: 33880623
DOI: 10.1007/164_2021_462.
Spadin Modulates Astrocytic Passive Conductance via Inhibition of TWIK-1/TREK-1 Heterodimeric Channels.
Bae Y, Choi J, Ryoo K, Kim A, Kwon O, Jung H
Int J Mol Sci. 2020; 21(24).
PMID: 33348878
PMC: 7765948.
DOI: 10.3390/ijms21249639.
Mechanistic insights into volatile anesthetic modulation of K2P channels.
Wague A, Joseph T, Woll K, Bu W, Vaidya K, Bhanu N
Elife. 2020; 9.
PMID: 33345771
PMC: 7781597.
DOI: 10.7554/eLife.59839.
K channel C-type gating involves asymmetric selectivity filter order-disorder transitions.
Lolicato M, Natale A, Abderemane-Ali F, Crottes D, Capponi S, Duman R
Sci Adv. 2020; 6(44).
PMID: 33127683
PMC: 7608817.
DOI: 10.1126/sciadv.abc9174.
Dual regulatory effects of PI(4,5)P on TREK-2 K channel through antagonizing interaction between the alkaline residues (K and R) in the cytosolic C-terminal helix.
Kim S, Kim M, Woo J, Kim S
Korean J Physiol Pharmacol. 2020; 24(6):555-561.
PMID: 33093276
PMC: 7585596.
DOI: 10.4196/kjpp.2020.24.6.555.
Intracellular activation of full-length human TREK-1 channel by hypoxia, high lactate, and low pH denotes polymodal integration by ischemic factors.
Mukherjee S, Sikdar S
Pflugers Arch. 2020; 473(2):167-183.
PMID: 33025137
DOI: 10.1007/s00424-020-02471-5.
TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.
Busserolles J, Ben Soussia I, Pouchol L, Marie N, Meleine M, Devilliers M
Br J Pharmacol. 2020; 177(20):4782-4795.
PMID: 32851651
PMC: 7520446.
DOI: 10.1111/bph.15243.